
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Peroxiredoxin 3 Is a Redox-Dependent Target of Thiostrepton in Malignant Mesothelioma Cells
Kheng Newick, Brian Cunniff, Kelsey Preston, et al.
PLoS ONE (2012) Vol. 7, Iss. 6, pp. e39404-e39404
Open Access | Times Cited: 62
Kheng Newick, Brian Cunniff, Kelsey Preston, et al.
PLoS ONE (2012) Vol. 7, Iss. 6, pp. e39404-e39404
Open Access | Times Cited: 62
Showing 1-25 of 62 citing articles:
The cysteine proteome
Young‐Mi Go, Joshua D. Chandler, Dean P. Jones
Free Radical Biology and Medicine (2015) Vol. 84, pp. 227-245
Open Access | Times Cited: 313
Young‐Mi Go, Joshua D. Chandler, Dean P. Jones
Free Radical Biology and Medicine (2015) Vol. 84, pp. 227-245
Open Access | Times Cited: 313
Form and Function in Cyclic Peptide Natural Products: A Pharmacokinetic Perspective
Andrew T. Bockus, Cayla M. McEwen, R. Scott Lokey
Current Topics in Medicinal Chemistry (2013) Vol. 13, Iss. 7, pp. 821-836
Closed Access | Times Cited: 175
Andrew T. Bockus, Cayla M. McEwen, R. Scott Lokey
Current Topics in Medicinal Chemistry (2013) Vol. 13, Iss. 7, pp. 821-836
Closed Access | Times Cited: 175
The Transcription Factor FOXM1 (Forkhead box M1)
Inken Wierstra
Advances in cancer research (2013), pp. 97-398
Closed Access | Times Cited: 170
Inken Wierstra
Advances in cancer research (2013), pp. 97-398
Closed Access | Times Cited: 170
FOXM1 (Forkhead box M1) in Tumorigenesis
Inken Wierstra
Advances in cancer research (2013), pp. 191-419
Closed Access | Times Cited: 168
Inken Wierstra
Advances in cancer research (2013), pp. 191-419
Closed Access | Times Cited: 168
Gentian Violet: a 19th century drug re‐emerges in the 21st century
Alexander Maley, Jack L. Arbiser
Experimental Dermatology (2013) Vol. 22, Iss. 12, pp. 775-780
Open Access | Times Cited: 137
Alexander Maley, Jack L. Arbiser
Experimental Dermatology (2013) Vol. 22, Iss. 12, pp. 775-780
Open Access | Times Cited: 137
Redox regulation of mammalian sperm capacitation
Cristián O’Flaherty
Asian Journal of Andrology (2015) Vol. 17, Iss. 4, pp. 583-583
Open Access | Times Cited: 131
Cristián O’Flaherty
Asian Journal of Andrology (2015) Vol. 17, Iss. 4, pp. 583-583
Open Access | Times Cited: 131
Immunomodulation, Bioavailability and Safety of Bacteriocins
Svetlana V. Guryanova
Life (2023) Vol. 13, Iss. 7, pp. 1521-1521
Open Access | Times Cited: 23
Svetlana V. Guryanova
Life (2023) Vol. 13, Iss. 7, pp. 1521-1521
Open Access | Times Cited: 23
New Insights into Understanding the Mechanisms, Pathogenesis, and Management of Malignant Mesotheliomas
Brooke T. Mossman, Arti Shukla, Nicholas H. Heintz, et al.
American Journal Of Pathology (2013) Vol. 182, Iss. 4, pp. 1065-1077
Open Access | Times Cited: 100
Brooke T. Mossman, Arti Shukla, Nicholas H. Heintz, et al.
American Journal Of Pathology (2013) Vol. 182, Iss. 4, pp. 1065-1077
Open Access | Times Cited: 100
Malignant mesothelioma as an oxidative stress-induced cancer: An update
Shan Hwu Chew, Shinya Toyokuni
Free Radical Biology and Medicine (2015) Vol. 86, pp. 166-178
Closed Access | Times Cited: 89
Shan Hwu Chew, Shinya Toyokuni
Free Radical Biology and Medicine (2015) Vol. 86, pp. 166-178
Closed Access | Times Cited: 89
Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer
Mark B. Hampton, Kate Angela Vick, John Skoko, et al.
Antioxidants and Redox Signaling (2017) Vol. 28, Iss. 7, pp. 591-608
Open Access | Times Cited: 67
Mark B. Hampton, Kate Angela Vick, John Skoko, et al.
Antioxidants and Redox Signaling (2017) Vol. 28, Iss. 7, pp. 591-608
Open Access | Times Cited: 67
Expression of peroxiredoxin 1 and 4 promotes human lung cancer malignancy.
Hong Jiang, Lisha Wu, Murli Mishra, et al.
PubMed (2014)
Closed Access | Times Cited: 54
Hong Jiang, Lisha Wu, Murli Mishra, et al.
PubMed (2014)
Closed Access | Times Cited: 54
Peroxiredoxins in Cancer and Response to Radiation Therapies
Tom E. Forshaw, Reetta Holmila, Kimberly Nelson, et al.
Antioxidants (2019) Vol. 8, Iss. 1, pp. 11-11
Open Access | Times Cited: 48
Tom E. Forshaw, Reetta Holmila, Kimberly Nelson, et al.
Antioxidants (2019) Vol. 8, Iss. 1, pp. 11-11
Open Access | Times Cited: 48
The Role of Peroxiredoxin Family in Cancer Signaling
Yosup Kim, Ho Hee Jang
Journal of Cancer Prevention (2019) Vol. 24, Iss. 2, pp. 65-71
Open Access | Times Cited: 44
Yosup Kim, Ho Hee Jang
Journal of Cancer Prevention (2019) Vol. 24, Iss. 2, pp. 65-71
Open Access | Times Cited: 44
Leveraging genetic diversity to identify small molecules that reverse mouse skeletal muscle insulin resistance
Stewart W. C. Masson, Søren Madsen, Kristen C. Cooke, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 14
Stewart W. C. Masson, Søren Madsen, Kristen C. Cooke, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 14
Peroxiredoxin 3 levels regulate a mitochondrial redox setpoint in malignant mesothelioma cells
Brian Cunniff, Alexandra N. Wozniak, Patrick Sweeney, et al.
Redox Biology (2014) Vol. 3, pp. 79-87
Open Access | Times Cited: 48
Brian Cunniff, Alexandra N. Wozniak, Patrick Sweeney, et al.
Redox Biology (2014) Vol. 3, pp. 79-87
Open Access | Times Cited: 48
Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma
Catherine M. Westbom, Joyce K. Thompson, Alan L. Leggett, et al.
PLoS ONE (2015) Vol. 10, Iss. 12, pp. e0145404-e0145404
Open Access | Times Cited: 46
Catherine M. Westbom, Joyce K. Thompson, Alan L. Leggett, et al.
PLoS ONE (2015) Vol. 10, Iss. 12, pp. e0145404-e0145404
Open Access | Times Cited: 46
The bacterial thiopeptide thiostrepton. An update of its mode of action, pharmacological properties and applications
Christian Bailly
European Journal of Pharmacology (2021) Vol. 914, pp. 174661-174661
Closed Access | Times Cited: 30
Christian Bailly
European Journal of Pharmacology (2021) Vol. 914, pp. 174661-174661
Closed Access | Times Cited: 30
Mitochondrial‐targeted nitroxides disrupt mitochondrial architecture and inhibit expression of peroxiredoxin 3 and FOXM1 in malignant mesothelioma cells
Brian Cunniff, Kira Benson, Jason Stumpff, et al.
Journal of Cellular Physiology (2012) Vol. 228, Iss. 4, pp. 835-845
Open Access | Times Cited: 39
Brian Cunniff, Kira Benson, Jason Stumpff, et al.
Journal of Cellular Physiology (2012) Vol. 228, Iss. 4, pp. 835-845
Open Access | Times Cited: 39
Diversity, function, and transcriptional regulation of gut innate lymphocytes
Andy K Y Lam, Adaline Wan Ling Ngan, Man‐Hong Leung, et al.
Frontiers in Oncology (2013) Vol. 4
Open Access | Times Cited: 37
Andy K Y Lam, Adaline Wan Ling Ngan, Man‐Hong Leung, et al.
Frontiers in Oncology (2013) Vol. 4
Open Access | Times Cited: 37
Peroxiredoxins and Beyond; Redox Systems Regulating Lung Physiology and Disease
Evan A. Elko, Brian Cunniff, David J. Seward, et al.
Antioxidants and Redox Signaling (2019) Vol. 31, Iss. 14, pp. 1070-1091
Open Access | Times Cited: 33
Evan A. Elko, Brian Cunniff, David J. Seward, et al.
Antioxidants and Redox Signaling (2019) Vol. 31, Iss. 14, pp. 1070-1091
Open Access | Times Cited: 33
Peroxiredoxin 3 regulates breast cancer progression via ERK-mediated MMP-1 expression
Pei‐Jou Chua, Suet-Hui Ow, Cheng-Teng Ng, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Pei‐Jou Chua, Suet-Hui Ow, Cheng-Teng Ng, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
FoxM1 as a Novel Therapeutic Target for Cancer Drug Therapy
Xinsen Xu, Runchen Miao, Yong Wan, et al.
Asian Pacific Journal of Cancer Prevention (2015) Vol. 16, Iss. 1, pp. 23-29
Open Access | Times Cited: 33
Xinsen Xu, Runchen Miao, Yong Wan, et al.
Asian Pacific Journal of Cancer Prevention (2015) Vol. 16, Iss. 1, pp. 23-29
Open Access | Times Cited: 33
The functional role of peroxiredoxin 3 in reactive oxygen species, apoptosis, and chemoresistance of cancer cells
Lianqin Li, Ai-Qun Yu
Journal of Cancer Research and Clinical Oncology (2015) Vol. 141, Iss. 12, pp. 2071-2077
Closed Access | Times Cited: 28
Lianqin Li, Ai-Qun Yu
Journal of Cancer Research and Clinical Oncology (2015) Vol. 141, Iss. 12, pp. 2071-2077
Closed Access | Times Cited: 28
A direct and continuous assay for the determination of thioredoxin reductase activity in cell lysates
Brian Cunniff, Gregg W. Snider, Nicholas Fredette, et al.
Analytical Biochemistry (2013) Vol. 443, Iss. 1, pp. 34-40
Open Access | Times Cited: 28
Brian Cunniff, Gregg W. Snider, Nicholas Fredette, et al.
Analytical Biochemistry (2013) Vol. 443, Iss. 1, pp. 34-40
Open Access | Times Cited: 28
Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma
Brian Cunniff, Kheng Newick, Kimberly Nelson, et al.
PLoS ONE (2015) Vol. 10, Iss. 5, pp. e0127310-e0127310
Open Access | Times Cited: 28
Brian Cunniff, Kheng Newick, Kimberly Nelson, et al.
PLoS ONE (2015) Vol. 10, Iss. 5, pp. e0127310-e0127310
Open Access | Times Cited: 28